Rates were 0.7% among those with alcohol use disorder and 1.6% for those with opioid use disorder presumably in those with comorbid diabetes/weight issues and substance use disorder
Many people will experience a weight loss plateau on semaglutide around the 12-to-15-month mark
Frye [email protected] This article was submitted to Neuroenergetics, Nutrition and Brain Health, a section of the journal Frontiers in Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
You may feel dizzy or lightheaded if this happens, especially if youre sensitive to blood sugar changes
People with a history of eating disorders Microdosing is particularly important for this population because the aggressive appetite suppression of standard doses can trigger disordered eating patterns
[1] Serious but rare risks include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration from gastrointestinal losses), and hypersensitivity reactions